MARK WERNHAM: Open Payments
NPI 1205849981 · ITHACA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 22 payments from 12 companies in 2025. Trend: 2023 $951 · 2024 $991 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Janssen Biotech, Inc. | 3 | $63 |
| PFIZER INC. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| GENZYME CORPORATION | 1 | $35 |
| ABBVIE INC. | 2 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| UCB, Inc. | 1 | $22 |
| Organon LLC | 1 | $21 |
Products named: COSENTYX, TREMFYA, DUPIXENT, CIBINQO, Sotyktu, SKYRIZI, ILUMYA, Bimzelx.
Industry payments across NY — which companies pay providers there.
